Objective: To assess the
effect of tourniquet application of intraoperative blood loss in placenta
accreta cases undergoing cesarean hysterectomy. Materials and methods: Nine
cases and twenty controls with USG and colour Doppler diagnosed placenta
accreta with previous cesarean section were chosen to utilize this novel
approach. These cases were planned for elective cesarean section followed by
hysterectomy. The twenty controls underwent a classical cesarean section
followed by total abdominal hysterectomy with the placentain situ. Among the nine cases,
after delivery of the fetus through upper segment cesarean section, a cotton
gauze tourniquet was applied all around the lower pole of uterus. Hysterectomy
was performed with placentain
situ. Abdomen closed after achieving complete haemostasis. Results: The
average operative time taken was 85 ± 11.72 minutes among cases and 98.25 ± 9.9
minutes among controls (p = 0.0039). Average blood loss was 1011.11 ± 99.3 ml
among the cases and 1855 ± 222.95 ml among the controls (p ≤ 0.0001). Average
requirement of blood transfusion required was two units for the cases and five
units for the controls (p = 0.0002). No intra-operative or post-operative
surgical complications were observed in any of the cases whereas the controls
reportedly had a few. All the mothers and babies were healthy at the time of
discharge. Conclusion: The presence of placenta accreta is associated with
major fetal and maternal complications. The technique of tourniquet application
is efficacious in minimizing the intra-operative blood loss and surgical
complications due to obstruction of operative field by bleeding and also by
preventing massive blood transfusion related complications.
References
[1]
Wu, S., Kocherginsky, M. and Hibbard, J.U. (2005) Abnormal Placentation: Twenty-Year Analysis. American Journal of Obstetrics & Gynecology, 192, 1458-1461.
[2]
Silver, R.M., Landon, M.B., Rouse, D.J., Leveno, K.J., Spong, C.Y., Thom, E.A., et al. (2006) Maternal Morbidity Associated with Multiple Repeat Cesarean Deliveries. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstetrics & Gynecology, 107, 1226-1232.
http://dx.doi.org/10.1097/01.AOG.0000219750.79480.84
[3]
Committee on Obstetric Practice (2002) ACOG Committee Opinion No. 266. Placenta Accreta. International Journal of Gynecology & Obstetrics, 77, 77-78.
[4]
Shellhaas, C.S., Gilbert, S., Landon, M.B., Varner, M.W., Leveno, K.J., Hauth, J.C., et al. (2009) The Frequency and Complication Rates of Hysterectomy Accompanying Cesarean Delivery. Eunice Kennedy Shriver National Institutes of Health and Human Development Maternal-Fetal Medicine Units Network. Obstetrics & Gynecology, 114, 224-229.
http://dx.doi.org/10.1097/AOG.0b013e3181ad9442
[5]
Eller, A., Porter, T., Soisson, P. and Silver, R. (2009) Optimal Management Strategies for Placenta Accreta. BJOG: An International Journal of Obstetrics & Gynaecology, 116, 648-654. http://dx.doi.org/10.1111/j.1471-0528.2008.02037.x
[6]
(2012) Placenta Accreta. Committee Opinion No. 529. American College of Obstetricians and Gynecologists. Obstetrics & Gynecology, 120, 207-211. http://dx.doi.org/10.1097/AOG.0b013e318262e340
[7]
Hudon, L., Belfort, M.A. and Broome, D.R. (1998) Diagnosis and Management of Placenta Percreta: A Review. Obstetrical & Gynecological Survey, 53, 509-517. http://dx.doi.org/10.1097/00006254-199808000-00024
[8]
O’Brien, J.M., Barton, J.R. and Donaldson, E.S. (1996) The Management of Placenta Percreta: Conservative and Operative Strategies. American Journal of Obstetrics & Gynecology, 175, 1632-1638.
http://dx.doi.org/10.1016/S0002-9378(96)70117-5
[9]
Eller, A.G., Bennett, M.A., Sharshiner, M., Masheter, C., Soisson, A.P., Dodson, M., et al. (2011) Maternal Morbidity in Cases of Placenta Accrete Managed by a Multidisciplinary Care Team Compared with Standard Obstetric Care. Obstetrics & Gynecology, 117, 331-337. http://dx.doi.org/10.1097/AOG.0b013e3182051db2
[10]
Tan, C.H., Tay, K.H., Sheah, K., Kwek, K., Wong, K., Tan, H.K., et al. (2007) Perioperative Endovascular Internal Iliac Artery Occlusion Balloon Placement in Management of Placenta Accreta. American Journal of Roentgenology, 189, 1158-1163. http://dx.doi.org/10.2214/AJR.07.2417
[11]
Ojala, K., Perala, J., Kariniemi, J., Ranta, P., Raudaskoski, T. and Tekay, A. (2005) Arterial Embolization and Prophylactic Catheterization for the Treatment for Severe Obstetric Hemorrhage. Acta Obstetricia et Gynecologica Scandinavica, 84, 1075-1080.
[12]
Shrivastava, V., Nageotte, M., Major, C., Haydon, M. and Wing, D. (2007) Case-Control Comparison of Cesarean Hysterectomy with and without Prophylactic Placement of Intravascular Balloon Catheters for Placenta Accreta. American Journal of Obstetrics & Gynecology, 197, 402.e1-402.e5.
[13]
Bishop, S., Butler, K., Monaghan, S., Chan, K., Murphy, G. and Edozien, L. (2011) Multiple Complications Following the Use of Prophylactic Internal Iliac Artery Balloon Catheterisation in a Patient with Placenta Percreta. International Journal of Obstetric Anesthesia, 20, 70-73. http://dx.doi.org/10.1016/j.ijoa.2010.09.012
[14]
Taylor, A., Sharma, M., Tsirkas, P., Di Spiezio Sardo, A., Setchell, M. and Magos, A. (2005) Reducing Blood Loss at Open Myomectomy Using Triple Tourniquets: A Randomised Controlled Trial. BJOG: An International Journal of Obstetrics & Gynaecology, 112, 340-345. http://dx.doi.org/10.1111/j.1471-0528.2004.00430.x